Clinical Trials on Idiopathic Pulmonary Hemosiderosis
Total 9890 results
-
Hal ChapmanNational Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
Xuzhou Traditional Chinese Medicine HospitalCompletedIdiopathic Pulmonary FibrosisChina
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
University Hospital, ToursCompletedIdiopathic Pulmonary FibrosisFrance
-
San Gerardo HospitalCompletedIdiopathic Pulmonary FibrosisItaly
-
KU LeuvenCompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisBelgium
-
Blade TherapeuticsWithdrawnIdiopathic Pulmonary FibrosisUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
Galapagos NVCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Ukraine
-
Boehringer IngelheimCompleted
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States
-
University Hospitals Coventry and Warwickshire...UnknownIdiopathic Pulmonary FibrosisUnited Kingdom
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Karolinska University HospitalUnknownIdiopathic Pulmonary FibrosisSweden
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
University of Alabama at BirminghamPulmonary Fibrosis FoundationCompletedIdiopathic Pulmonary FibrosisUnited States
-
Alicia GerkePulmonary Fibrosis FoundationTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
University of NottinghamGlaxoSmithKline; McMaster University; Medical Research Council; CRAFT ConsortiumCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of PittsburghUniversity of Pennsylvania; Milton S. Hershey Medical Center; Temple University; Geisinger ClinicCompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Clinica Universidad de Navarra, Universidad de...CompletedIdiopathic Pulmonary FibrosisSpain
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Germany
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Peking Union Medical College HospitalStanford UniversityUnknownIdiopathic Pulmonary FibrosisChina
-
AstraZenecaMedImmune LLCCompleted
-
Hoffmann-La RocheWithdrawnIdiopathic Pulmonary Fibrosis
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
University of East AngliaCompleted
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Belgium, Germany, France, Sweden, Austria, Denmark, Italy
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
University of PittsburghWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Schön Klinik Berchtesgadener LandCompletedIdiopathic Pulmonary FibrosisGermany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaTerminatedIdiopathic Pulmonary FibrosisItaly
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
Royal Brompton & Harefield NHS Foundation TrustGlaxoSmithKlineCompleted
-
ActelionWithdrawnIdiopathic Pulmonary Fibrosis
-
Kasiak Research Pvt. Ltd.UnknownIdiopathic Pulmonary FibrosisIndia
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisBelgium, France, Germany, Israel, Spain, United States, Switzerland, Colombia, Mexico, Italy, Czech Republic, Australia, Canada, Austria, Poland, United Kingdom, Argentina, Netherlands, Peru, Ireland, Brazil, Chile
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Beijing Kawin Technology Share-Holding Co., Ltd.UnknownIdiopathic Pulmonary FibrosisChina
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of California, Los AngelesUnknownMinocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyIdiopathic Pulmonary FibrosisUnited States
-
Novartis PharmaceuticalsCompletedTransfusional HemosiderosisEgypt, Spain, United Kingdom, Jordan